» Authors » Nicholas Maskell

Nicholas Maskell

Explore the profile of Nicholas Maskell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 196
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, et al.
Elife . 2023 Jun; 12. PMID: 37310006
Coronavirus disease-19 (COVID-19) causes immune perturbations which may persist long term, and patients frequently report ongoing symptoms for months after recovery. We assessed immune activation at 3-12 months post hospital...
2.
MacGowan A, Hamilton F, Bayliss M, Read L, Attwood M, Noel A, et al.
Microb Drug Resist . 2022 Jan; 28(5):611-612. PMID: 35099290
No abstract available.
3.
Carande E, Brown K, Jackson D, Maskell N, Kouzaris L, Greene G, et al.
Angiology . 2021 Aug; 73(2):139-145. PMID: 34459224
We investigated the predictors, aetiology and long-term outcomes of acute kidney injury (AKI) following urgent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Acute kidney injury occurred in 198...
4.
MacGowan A, Hamilton F, Bayliss M, Read L, Attwood M, Noel A, et al.
J Glob Antimicrob Resist . 2021 Jan; 24:178-179. PMID: 33460844
No abstract available.
5.
Brims F, Meniawy T, Duffus I, De Fonseka D, Segal A, Creaney J, et al.
J Thorac Oncol . 2016 Jan; 11(4):573-82. PMID: 26776867
Introduction: Malignant pleural mesothelioma (MPM) is a rare cancer with a heterogeneous prognosis. Prognostic models are not widely utilized clinically. Classification and regression tree (CART) analysis examines the interaction of...
6.
Tschopp J, Bintcliffe O, Astoul P, Canalis E, Driesen P, Janssen J, et al.
Eur Respir J . 2015 Jun; 46(2):321-35. PMID: 26113675
Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant recurrence rate. Recent advances in treatment have been variably implemented in clinical practice. This statement reviews the latest developments...